ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment (2020)
Silvestre, Renata Nacasaki; Eitler, J.; Fantacini, Daianne Maciely Carvalho ; Farias, Kelen Cristina Ribeiro Malmegrim de ; Swiech, Kamilla ; Covas, Dimas Tadeu; Tonn, T.; Picanço-Castro, Virgínia
Source: Hematology, Transfusion and Cell Therapy. Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular (HemoPlay 2020). Unidades: FCFRP, FMRP
Subjects: LEUCEMIA, LINFOMA, LINFÓCITOS B, LINFÓCITOS T
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVESTRE, Renata Nacasaki et al. Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2020.10.703. Acesso em: 16 nov. 2024. , 2020
APA
Silvestre, R. N., Eitler, J., Fantacini, D. M. C., Farias, K. C. R. M. de, Swiech, K., Covas, D. T., et al. (2020). Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2020.10.703
NLM
Silvestre RN, Eitler J, Fantacini DMC, Farias KCRM de, Swiech K, Covas DT, Tonn T, Picanço-Castro V. Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S418.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.htct.2020.10.703
Vancouver
Silvestre RN, Eitler J, Fantacini DMC, Farias KCRM de, Swiech K, Covas DT, Tonn T, Picanço-Castro V. Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S418.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.htct.2020.10.703
Trabalho de evento-resumo periodico
Optimizing intracellular signaling domains for CAR-NK cells (2020)
Azevedo, Júlia Teixeira Cottas de; Silvestre, Renata Nacasaki; Pessoni, André Moreira ; Farias, Kelen Cristina Ribeiro Malmegrim de ; Covas, Dimas Tadeu; Picanço-Castro, Virgínia
Source: Hematology, Transfusion and Cell Therapy. Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular (HemoPlay 2020). Unidades: FCFRP, FMRP
Subjects: SISTEMA IMUNE, NEOPLASIAS, PROLIFERAÇÃO CELULAR, LEUCEMIA, LINFOMA, TRANSDUÇÃO DE SINAL CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AZEVEDO, Júlia Teixeira Cottas de et al. Optimizing intracellular signaling domains for CAR-NK cells. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2020.10.710. Acesso em: 16 nov. 2024. , 2020
APA
Azevedo, J. T. C. de, Silvestre, R. N., Pessoni, A. M., Farias, K. C. R. M. de, Covas, D. T., & Picanço-Castro, V. (2020). Optimizing intracellular signaling domains for CAR-NK cells. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2020.10.710
NLM
Azevedo JTC de, Silvestre RN, Pessoni AM, Farias KCRM de, Covas DT, Picanço-Castro V. Optimizing intracellular signaling domains for CAR-NK cells [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S422-S423.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.htct.2020.10.710
Vancouver
Azevedo JTC de, Silvestre RN, Pessoni AM, Farias KCRM de, Covas DT, Picanço-Castro V. Optimizing intracellular signaling domains for CAR-NK cells [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S422-S423.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.htct.2020.10.710
Trabalho de evento-resumo periodico
Development of a platform for tracking CAR-T cell persistence using qPCR and multiparametric flow cytometry for preclinical and clinical studies (2020)
Batista, L. C.; Brand, Heloisa ; Fantacini, Daianne Maciely Carvalho ; Covas, Dimas Tadeu ; Souza, L. E. B.
Source: Hematology, Transfusion and Cell Therapy. Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular - HemoPlay. Unidade: FMRP
Subjects: LEUCEMIA, LINFÓCITOS T, CITOMETRIA DE FLUXO, IMUNOFENOTIPAGEM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BATISTA, L. C. et al. Development of a platform for tracking CAR-T cell persistence using qPCR and multiparametric flow cytometry for preclinical and clinical studies. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2020.10.701. Acesso em: 16 nov. 2024. , 2020
APA
Batista, L. C., Brand, H., Fantacini, D. M. C., Covas, D. T., & Souza, L. E. B. (2020). Development of a platform for tracking CAR-T cell persistence using qPCR and multiparametric flow cytometry for preclinical and clinical studies. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2020.10.701
NLM
Batista LC, Brand H, Fantacini DMC, Covas DT, Souza LEB. Development of a platform for tracking CAR-T cell persistence using qPCR and multiparametric flow cytometry for preclinical and clinical studies [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S416-S417.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.htct.2020.10.701
Vancouver
Batista LC, Brand H, Fantacini DMC, Covas DT, Souza LEB. Development of a platform for tracking CAR-T cell persistence using qPCR and multiparametric flow cytometry for preclinical and clinical studies [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S416-S417.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.htct.2020.10.701
Artigo de periodico
Mesenchymal stromal cell infusion to treat steroid-refractory acute GvHD III/IV after hematopoietic stem cell transplantation (2017)
Dotoli, G. M.; Santis, G. C. de; Orellana, M. D.; Prata, K. de Lima; Caruso, S. R.; Fernandes, T. R.; Colturato, V. A. Rensi; Kondo, A. T.; Hamerschlak, N.; Simões, Belinda Pinto; Covas, Dimas Tadeu
Source: Bone Marrow Transplantation. Unidade: FMRP
Subjects: LEUCEMIA, DOENÇA ENXERTO-HOSPEDEIRO, CÉLULAS-TRONCO, SOBREVIVÊNCIA LIVRE DE DOENÇA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DOTOLI, G. M. et al. Mesenchymal stromal cell infusion to treat steroid-refractory acute GvHD III/IV after hematopoietic stem cell transplantation. Bone Marrow Transplantation, v. 52, n. 6, p. 859-862, 2017Tradução . . Disponível em: https://doi.org/10.1038/bmt.2017.35. Acesso em: 16 nov. 2024.
APA
Dotoli, G. M., Santis, G. C. de, Orellana, M. D., Prata, K. de L., Caruso, S. R., Fernandes, T. R., et al. (2017). Mesenchymal stromal cell infusion to treat steroid-refractory acute GvHD III/IV after hematopoietic stem cell transplantation. Bone Marrow Transplantation, 52( 6), 859-862. doi:10.1038/bmt.2017.35
NLM
Dotoli GM, Santis GC de, Orellana MD, Prata K de L, Caruso SR, Fernandes TR, Colturato VAR, Kondo AT, Hamerschlak N, Simões BP, Covas DT. Mesenchymal stromal cell infusion to treat steroid-refractory acute GvHD III/IV after hematopoietic stem cell transplantation [Internet]. Bone Marrow Transplantation. 2017 ; 52( 6): 859-862.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1038/bmt.2017.35
Vancouver
Dotoli GM, Santis GC de, Orellana MD, Prata K de L, Caruso SR, Fernandes TR, Colturato VAR, Kondo AT, Hamerschlak N, Simões BP, Covas DT. Mesenchymal stromal cell infusion to treat steroid-refractory acute GvHD III/IV after hematopoietic stem cell transplantation [Internet]. Bone Marrow Transplantation. 2017 ; 52( 6): 859-862.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1038/bmt.2017.35
Artigo de periodico
Downregulation of histone methyltransferase EHMT2 in CD4+ T-cells may protect HTLV-1-infected individuals against HAM/TSP development (2017)
Colaço, Camila Schoueri; Matos, Adriano Reis de; Estrêla, Martha Silva; Rocha-Júnior, Maurício Cristiano; Otaguiri, Kátia Kaori; Rodrigues, Evandra Strazza; Takayanagui, Osvaldo Massaiti; Covas, Dimas Tadeu; Kashima, Simone; Silva, Fabio Pittella; Haddad, Rodrigo
Source: Archives of Virology. Unidade: FMRP
Subjects: LEUCEMIA, PREDISPOSIÇÃO GENÉTICA PARA DOENÇA, ANTÍGENOS DE HISTOCOMPATIBILIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COLAÇO, Camila Schoueri et al. Downregulation of histone methyltransferase EHMT2 in CD4+ T-cells may protect HTLV-1-infected individuals against HAM/TSP development. Archives of Virology, v. 162, n. 10, p. 3131-3136, 2017Tradução . . Disponível em: https://doi.org/10.1007/s00705-017-3428-8. Acesso em: 16 nov. 2024.
APA
Colaço, C. S., Matos, A. R. de, Estrêla, M. S., Rocha-Júnior, M. C., Otaguiri, K. K., Rodrigues, E. S., et al. (2017). Downregulation of histone methyltransferase EHMT2 in CD4+ T-cells may protect HTLV-1-infected individuals against HAM/TSP development. Archives of Virology, 162( 10), 3131-3136. doi:10.1007/s00705-017-3428-8
NLM
Colaço CS, Matos AR de, Estrêla MS, Rocha-Júnior MC, Otaguiri KK, Rodrigues ES, Takayanagui OM, Covas DT, Kashima S, Silva FP, Haddad R. Downregulation of histone methyltransferase EHMT2 in CD4+ T-cells may protect HTLV-1-infected individuals against HAM/TSP development [Internet]. Archives of Virology. 2017 ; 162( 10): 3131-3136.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s00705-017-3428-8
Vancouver
Colaço CS, Matos AR de, Estrêla MS, Rocha-Júnior MC, Otaguiri KK, Rodrigues ES, Takayanagui OM, Covas DT, Kashima S, Silva FP, Haddad R. Downregulation of histone methyltransferase EHMT2 in CD4+ T-cells may protect HTLV-1-infected individuals against HAM/TSP development [Internet]. Archives of Virology. 2017 ; 162( 10): 3131-3136.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s00705-017-3428-8
Artigo de periodico
Potential roles of microRNA-29a in the molecular pathophysiology of T-cell acute lymphoblastic leukemia (2015)
Oliveira, Lucila H.; Schiavinato, Josiane Lilian dos Santos; Fráguas, Mariane S.; Lucena-Araújo, Antonio R.; Haddad, Rodrigo; Araújo, Amélia Goes; Dalmazzo, Leandro F.; Rego, Eduardo Magalhães; Covas, Dimas Tadeu; Zago, Marco Antonio; Panepucci, Rodrigo Alexandre
Source: Cancer Science. Unidade: FMRP
Subjects: RNA, REGULAÇÃO GÊNICA, LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Lucila H. et al. Potential roles of microRNA-29a in the molecular pathophysiology of T-cell acute lymphoblastic leukemia. Cancer Science, v. 106, n. 10, p. 1264-1277, 2015Tradução . . Disponível em: https://doi.org/10.1111/cas.12766. Acesso em: 16 nov. 2024.
APA
Oliveira, L. H., Schiavinato, J. L. dos S., Fráguas, M. S., Lucena-Araújo, A. R., Haddad, R., Araújo, A. G., et al. (2015). Potential roles of microRNA-29a in the molecular pathophysiology of T-cell acute lymphoblastic leukemia. Cancer Science, 106( 10), 1264-1277. doi:10.1111/cas.12766
NLM
Oliveira LH, Schiavinato JL dos S, Fráguas MS, Lucena-Araújo AR, Haddad R, Araújo AG, Dalmazzo LF, Rego EM, Covas DT, Zago MA, Panepucci RA. Potential roles of microRNA-29a in the molecular pathophysiology of T-cell acute lymphoblastic leukemia [Internet]. Cancer Science. 2015 ; 106( 10): 1264-1277.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/cas.12766
Vancouver
Oliveira LH, Schiavinato JL dos S, Fráguas MS, Lucena-Araújo AR, Haddad R, Araújo AG, Dalmazzo LF, Rego EM, Covas DT, Zago MA, Panepucci RA. Potential roles of microRNA-29a in the molecular pathophysiology of T-cell acute lymphoblastic leukemia [Internet]. Cancer Science. 2015 ; 106( 10): 1264-1277.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/cas.12766
Artigo de periodico
Significant differences in integration sites of Moloney murine leukemia virus/Moloney murine sarcoma virus retroviral vector carrying recombinant coagulation factor IX in two human cell lines (2015)
Castilho-Fernandes, Andrielle; Fontes, Aparecida Maria; Abraham, Kuruvilla Joseph ; Freitas, Marcela Cristina Corrêa de; Rosa, Nathalia Gonsales da; Picanço-Castro, Virginia; Russo-Carbolante, Elisa Maria de Sousa; Covas, Dimas Tadeu
Source: Biotechnology Letters. Unidade: FMRP
Subjects: LEUCEMIA, GENÉTICA, PROTEÍNAS RECOMBINANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTILHO-FERNANDES, Andrielle et al. Significant differences in integration sites of Moloney murine leukemia virus/Moloney murine sarcoma virus retroviral vector carrying recombinant coagulation factor IX in two human cell lines. Biotechnology Letters, v. 37, n. 5, p. 991-1001, 2015Tradução . . Disponível em: https://doi.org/10.1007/s10529-014-1764-2. Acesso em: 16 nov. 2024.
APA
Castilho-Fernandes, A., Fontes, A. M., Abraham, K. J., Freitas, M. C. C. de, Rosa, N. G. da, Picanço-Castro, V., et al. (2015). Significant differences in integration sites of Moloney murine leukemia virus/Moloney murine sarcoma virus retroviral vector carrying recombinant coagulation factor IX in two human cell lines. Biotechnology Letters, 37( 5), 991-1001. doi:10.1007/s10529-014-1764-2
NLM
Castilho-Fernandes A, Fontes AM, Abraham KJ, Freitas MCC de, Rosa NG da, Picanço-Castro V, Russo-Carbolante EM de S, Covas DT. Significant differences in integration sites of Moloney murine leukemia virus/Moloney murine sarcoma virus retroviral vector carrying recombinant coagulation factor IX in two human cell lines [Internet]. Biotechnology Letters. 2015 ; 37( 5): 991-1001.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s10529-014-1764-2
Vancouver
Castilho-Fernandes A, Fontes AM, Abraham KJ, Freitas MCC de, Rosa NG da, Picanço-Castro V, Russo-Carbolante EM de S, Covas DT. Significant differences in integration sites of Moloney murine leukemia virus/Moloney murine sarcoma virus retroviral vector carrying recombinant coagulation factor IX in two human cell lines [Internet]. Biotechnology Letters. 2015 ; 37( 5): 991-1001.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s10529-014-1764-2
Artigo de periodico
Genes related to antiviral activity, cell migration, and lysis are differentially expressed in 'CD4 POT.+' T cells in human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients (2014)
Pinto, Mariana Tomazini; Malta, Tathiane Maistro; Rodrigues, Evandra Strazza; Pinheiro, Daniel Guariz; Panepucci, Rodrigo Alexandre; Farias, Kelen Cristina Ribeiro Malmegrim; Sousa, Alessandra de Paula; Takayanagui, Osvaldo Massaiti; Tanaka, Yuetsu; Covas, Dimas Tadeu; Kashima, Simone
Source: AIDS Research and Human Retroviruses. Unidades: FCFRP, FMRP
Subjects: EXPRESSÃO GÊNICA, LEUCEMIA, VÍRUS, CÉLULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINTO, Mariana Tomazini et al. Genes related to antiviral activity, cell migration, and lysis are differentially expressed in 'CD4 POT.+' T cells in human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients. AIDS Research and Human Retroviruses, v. 30, n. 6, p. 610-622, 2014Tradução . . Disponível em: https://doi.org/10.1089/aid.2013.0109. Acesso em: 16 nov. 2024.
APA
Pinto, M. T., Malta, T. M., Rodrigues, E. S., Pinheiro, D. G., Panepucci, R. A., Farias, K. C. R. M., et al. (2014). Genes related to antiviral activity, cell migration, and lysis are differentially expressed in 'CD4 POT.+' T cells in human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients. AIDS Research and Human Retroviruses, 30( 6), 610-622. doi:10.1089/aid.2013.0109
NLM
Pinto MT, Malta TM, Rodrigues ES, Pinheiro DG, Panepucci RA, Farias KCRM, Sousa A de P, Takayanagui OM, Tanaka Y, Covas DT, Kashima S. Genes related to antiviral activity, cell migration, and lysis are differentially expressed in 'CD4 POT.+' T cells in human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients [Internet]. AIDS Research and Human Retroviruses. 2014 ; 30( 6): 610-622.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1089/aid.2013.0109
Vancouver
Pinto MT, Malta TM, Rodrigues ES, Pinheiro DG, Panepucci RA, Farias KCRM, Sousa A de P, Takayanagui OM, Tanaka Y, Covas DT, Kashima S. Genes related to antiviral activity, cell migration, and lysis are differentially expressed in 'CD4 POT.+' T cells in human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients [Internet]. AIDS Research and Human Retroviruses. 2014 ; 30( 6): 610-622.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1089/aid.2013.0109
Artigo de periodico
Interleukin-18 and interferon-gamma polymorphisms are implicated on proviral load and susceptibility to human T-lymphotropic virus type 1 infection (2012)
Rocha Junior, Maurício Cristiano; Haddad, R.; Alves, D. C. Cilião; Wagatsuma, V. M. de Deus; Mendes Júnior, Celso Teixeira; Deghaide, Neifi Hassan Saloum; Takayanagui, Osvaldo Massaiti; Covas, Dimas Tadeu; Donadi, Eduardo Antônio; Kashima, Simone
Source: Tissue Antigens. Unidades: FMRP, FFCLRP
Subjects: LINFÓCITOS T, INTERLEUCINAS, LEUCEMIA, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA JUNIOR, Maurício Cristiano et al. Interleukin-18 and interferon-gamma polymorphisms are implicated on proviral load and susceptibility to human T-lymphotropic virus type 1 infection. Tissue Antigens, v. 80, n. 2, p. 143-150, 2012Tradução . . Disponível em: https://doi.org/10.1111/j.1399-0039.2012.01887.x. Acesso em: 16 nov. 2024.
APA
Rocha Junior, M. C., Haddad, R., Alves, D. C. C., Wagatsuma, V. M. de D., Mendes Júnior, C. T., Deghaide, N. H. S., et al. (2012). Interleukin-18 and interferon-gamma polymorphisms are implicated on proviral load and susceptibility to human T-lymphotropic virus type 1 infection. Tissue Antigens, 80( 2), 143-150. doi:10.1111/j.1399-0039.2012.01887.x
NLM
Rocha Junior MC, Haddad R, Alves DCC, Wagatsuma VM de D, Mendes Júnior CT, Deghaide NHS, Takayanagui OM, Covas DT, Donadi EA, Kashima S. Interleukin-18 and interferon-gamma polymorphisms are implicated on proviral load and susceptibility to human T-lymphotropic virus type 1 infection [Internet]. Tissue Antigens. 2012 ; 80( 2): 143-150.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/j.1399-0039.2012.01887.x
Vancouver
Rocha Junior MC, Haddad R, Alves DCC, Wagatsuma VM de D, Mendes Júnior CT, Deghaide NHS, Takayanagui OM, Covas DT, Donadi EA, Kashima S. Interleukin-18 and interferon-gamma polymorphisms are implicated on proviral load and susceptibility to human T-lymphotropic virus type 1 infection [Internet]. Tissue Antigens. 2012 ; 80( 2): 143-150.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/j.1399-0039.2012.01887.x
Artigo de periodico
Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil (2010)
Oliveira, Luciana Correa Oliveira de; Romano, Lucas Gabriel M.; Prado Júnior, Benedito de Pina Almeida; Covas, Dimas Tadeu; Rego, Eduardo Magalhaes; Santis, Gil Cunha de
Source: Medical Oncology. Unidade: FMRP
Subjects: LEUCEMIA, LEUCÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Luciana Correa Oliveira de et al. Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil. Medical Oncology, v. 27, n. 4, p. 1254-1259, 2010Tradução . . Disponível em: https://doi.org/10.1007/s12032-009-9367-9. Acesso em: 16 nov. 2024.
APA
Oliveira, L. C. O. de, Romano, L. G. M., Prado Júnior, B. de P. A., Covas, D. T., Rego, E. M., & Santis, G. C. de. (2010). Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil. Medical Oncology, 27( 4), 1254-1259. doi:10.1007/s12032-009-9367-9
NLM
Oliveira LCO de, Romano LGM, Prado Júnior B de PA, Covas DT, Rego EM, Santis GC de. Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil [Internet]. Medical Oncology. 2010 ; 27( 4): 1254-1259.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s12032-009-9367-9
Vancouver
Oliveira LCO de, Romano LGM, Prado Júnior B de PA, Covas DT, Rego EM, Santis GC de. Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil [Internet]. Medical Oncology. 2010 ; 27( 4): 1254-1259.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s12032-009-9367-9
Trabalho de evento-resumo periodico
BCR-ABL oncoprotein modulates mirna involved in apoptosis regulation (2009)
Ferreira, A. F.; Silva Júnior, Wilson Araújo da; Silva, I. T.; Azevedo, R.; Tognon, R.; Zanichelli, M. A.; Hamerschlak, N.; Amarante-Mendes, João Gustavo Pessini ; Covas, Dimas Tadeu; Kashima, S.; Souza, A. M.; Castro, F. A.
Source: Haematologica. Conference titles: Congress of the European Hematology Association. Unidades: FMRP, ICB
Subjects: APOPTOSE, LEUCEMIA, FENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, A. F. et al. BCR-ABL oncoprotein modulates mirna involved in apoptosis regulation. Haematologica. Pavia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 16 nov. 2024. , 2009
APA
Ferreira, A. F., Silva Júnior, W. A. da, Silva, I. T., Azevedo, R., Tognon, R., Zanichelli, M. A., et al. (2009). BCR-ABL oncoprotein modulates mirna involved in apoptosis regulation. Haematologica. Pavia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Ferreira AF, Silva Júnior WA da, Silva IT, Azevedo R, Tognon R, Zanichelli MA, Hamerschlak N, Amarante-Mendes JGP, Covas DT, Kashima S, Souza AM, Castro FA. BCR-ABL oncoprotein modulates mirna involved in apoptosis regulation. Haematologica. 2009 ; 94 126-127.[citado 2024 nov. 16 ]
Vancouver
Ferreira AF, Silva Júnior WA da, Silva IT, Azevedo R, Tognon R, Zanichelli MA, Hamerschlak N, Amarante-Mendes JGP, Covas DT, Kashima S, Souza AM, Castro FA. BCR-ABL oncoprotein modulates mirna involved in apoptosis regulation. Haematologica. 2009 ; 94 126-127.[citado 2024 nov. 16 ]
Trabalho de evento-resumo periodico
Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil (2009)
Oliveira, Luciana Correa Oliveira de; Romano, Lucas Gabriel M.; Prado Júnior, Benedito Pina de Almeida; Covas, Dimas Tadeu; Rego, Eduardo Magalhaes; De Santis, Gil Cunha
Source: Blood. Conference titles: Annual Meeting and Exposition of The American Society of Hematology. Unidade: FMRP
Assunto: LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Luciana Correa Oliveira de et al. Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 16 nov. 2024. , 2009
APA
Oliveira, L. C. O. de, Romano, L. G. M., Prado Júnior, B. P. de A., Covas, D. T., Rego, E. M., & De Santis, G. C. (2009). Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Oliveira LCO de, Romano LGM, Prado Júnior BP de A, Covas DT, Rego EM, De Santis GC. Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil. Blood. 2009 ; 114( 22): 572.[citado 2024 nov. 16 ]
Vancouver
Oliveira LCO de, Romano LGM, Prado Júnior BP de A, Covas DT, Rego EM, De Santis GC. Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil. Blood. 2009 ; 114( 22): 572.[citado 2024 nov. 16 ]
Artigo de periodico
Mesenchymal stem cells from patients with chronic myeloid leukemia do not express BCR-ABL and have absence of chimerism after allogeneic bone marrow transplant (2007)
Carrara, R. C. V.; Orellana, M. D.; Fontes, A. M.; Palma, P. V. B.; Kashima, S.; Mendes, M. R.; Coutinho, M. A.; Voltarelli, Júlio César; Covas, Dimas Tadeu
Source: Brazilian Journal of Medical and Biological Research. Unidade: FMRP
Subjects: CÉLULAS-TRONCO, TRANSPLANTE DE MEDULA ÓSSEA, LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARRARA, R. C. V. et al. Mesenchymal stem cells from patients with chronic myeloid leukemia do not express BCR-ABL and have absence of chimerism after allogeneic bone marrow transplant. Brazilian Journal of Medical and Biological Research, v. 40, n. 1, p. 57-67, 2007Tradução . . Disponível em: https://doi.org/10.1590/s0100-879x2006005000055. Acesso em: 16 nov. 2024.
APA
Carrara, R. C. V., Orellana, M. D., Fontes, A. M., Palma, P. V. B., Kashima, S., Mendes, M. R., et al. (2007). Mesenchymal stem cells from patients with chronic myeloid leukemia do not express BCR-ABL and have absence of chimerism after allogeneic bone marrow transplant. Brazilian Journal of Medical and Biological Research, 40( 1), 57-67. doi:10.1590/s0100-879x2006005000055
NLM
Carrara RCV, Orellana MD, Fontes AM, Palma PVB, Kashima S, Mendes MR, Coutinho MA, Voltarelli JC, Covas DT. Mesenchymal stem cells from patients with chronic myeloid leukemia do not express BCR-ABL and have absence of chimerism after allogeneic bone marrow transplant [Internet]. Brazilian Journal of Medical and Biological Research. 2007 ; 40( 1): 57-67.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1590/s0100-879x2006005000055
Vancouver
Carrara RCV, Orellana MD, Fontes AM, Palma PVB, Kashima S, Mendes MR, Coutinho MA, Voltarelli JC, Covas DT. Mesenchymal stem cells from patients with chronic myeloid leukemia do not express BCR-ABL and have absence of chimerism after allogeneic bone marrow transplant [Internet]. Brazilian Journal of Medical and Biological Research. 2007 ; 40( 1): 57-67.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1590/s0100-879x2006005000055
Trabalho de evento-resumo
Differential expression of the flice-inhibitory protein, c-flip, in cd34+ cells myelogenous leukemia, polycythemia vera and essential thombocythemia (2007)
Gasparotto, Elainy P. L.; Carrara, Rita de Cássia Viu; Tognon, Raquel; Ferreira, Aline F.; Oliveira, Gislaine L. V. de; Souto, Elizabeth X.; Zanichelli, Maria A.; Simões, Belinda P.; Velano, Carlos; Kashima, Simone; Covas, Dimas Tadeu; Castro, Fabíola Attié de; Souza, Ana Maria de Souza
Source: Abstract. Conference titles: International Congress of Pharmaceutical Sciences (CIFARP). Unidades: FMRP, FCFRP
Assunto: LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GASPAROTTO, Elainy P. L. et al. Differential expression of the flice-inhibitory protein, c-flip, in cd34+ cells myelogenous leukemia, polycythemia vera and essential thombocythemia. 2007, Anais.. São Paulo: ABCF, 2007. . Acesso em: 16 nov. 2024.
APA
Gasparotto, E. P. L., Carrara, R. de C. V., Tognon, R., Ferreira, A. F., Oliveira, G. L. V. de, Souto, E. X., et al. (2007). Differential expression of the flice-inhibitory protein, c-flip, in cd34+ cells myelogenous leukemia, polycythemia vera and essential thombocythemia. In Abstract. São Paulo: ABCF.
NLM
Gasparotto EPL, Carrara R de CV, Tognon R, Ferreira AF, Oliveira GLV de, Souto EX, Zanichelli MA, Simões BP, Velano C, Kashima S, Covas DT, Castro FA de, Souza AM de S. Differential expression of the flice-inhibitory protein, c-flip, in cd34+ cells myelogenous leukemia, polycythemia vera and essential thombocythemia. Abstract. 2007 ;[citado 2024 nov. 16 ]
Vancouver
Gasparotto EPL, Carrara R de CV, Tognon R, Ferreira AF, Oliveira GLV de, Souto EX, Zanichelli MA, Simões BP, Velano C, Kashima S, Covas DT, Castro FA de, Souza AM de S. Differential expression of the flice-inhibitory protein, c-flip, in cd34+ cells myelogenous leukemia, polycythemia vera and essential thombocythemia. Abstract. 2007 ;[citado 2024 nov. 16 ]
Trabalho de evento-resumo
The profile of death receptors, the anti-apoptotic c-flip in cells presents in chronic myeloid leukemia after treatment with tk inhibitors (2007)
Ferreira, Aline Fernanda; Vilela, Gislaine L.; Collassanti, Maria D. S.; Zanichelli, Maria; Hamerschalak, Nelson; Amarante-Mendes, João Gustavo Pessini ; Covas, Dimas Tadeu; Kashima, Simone; Castro, Fabíola Attié de
Source: Abstract. Conference titles: International Congress of Pharmaceutical Sciences (CIFARP). Unidades: FMRP, FCFRP
Subjects: LEUCEMIA, CÉLULAS DA MEDULA ÓSSEA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Aline Fernanda et al. The profile of death receptors, the anti-apoptotic c-flip in cells presents in chronic myeloid leukemia after treatment with tk inhibitors. 2007, Anais.. São Paulo: ABCF, 2007. . Acesso em: 16 nov. 2024.
APA
Ferreira, A. F., Vilela, G. L., Collassanti, M. D. S., Zanichelli, M., Hamerschalak, N., Amarante-Mendes, J. G. P., et al. (2007). The profile of death receptors, the anti-apoptotic c-flip in cells presents in chronic myeloid leukemia after treatment with tk inhibitors. In Abstract. São Paulo: ABCF.
NLM
Ferreira AF, Vilela GL, Collassanti MDS, Zanichelli M, Hamerschalak N, Amarante-Mendes JGP, Covas DT, Kashima S, Castro FA de. The profile of death receptors, the anti-apoptotic c-flip in cells presents in chronic myeloid leukemia after treatment with tk inhibitors. Abstract. 2007 ;[citado 2024 nov. 16 ]
Vancouver
Ferreira AF, Vilela GL, Collassanti MDS, Zanichelli M, Hamerschalak N, Amarante-Mendes JGP, Covas DT, Kashima S, Castro FA de. The profile of death receptors, the anti-apoptotic c-flip in cells presents in chronic myeloid leukemia after treatment with tk inhibitors. Abstract. 2007 ;[citado 2024 nov. 16 ]
Trabalho de evento-resumo periodico
Differential expression of the flice-inhibitory protein, C-flip, in 'CD34 POT.+'cells in chronic myelogenous leukemia, polycythemia vera and essential trombocythemia (2007)
Gasparotto, G.; Carrara, R. V.; Zanichelli, M. A.; Souto, E. X.; Simões, Belinda Pinto; Vellano, C.; Covas, Dimas Tadeu; Kashima, S.; Souza, Ana Maria de; Castro, Fabíola Attié de
Source: Haematologica. Conference titles: Congress of The European Hematology Association. Unidades: FMRP, FCFRP
Assunto: LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GASPAROTTO, G. et al. Differential expression of the flice-inhibitory protein, C-flip, in 'CD34 POT.+'cells in chronic myelogenous leukemia, polycythemia vera and essential trombocythemia. Haematologica. Pavia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 16 nov. 2024. , 2007
APA
Gasparotto, G., Carrara, R. V., Zanichelli, M. A., Souto, E. X., Simões, B. P., Vellano, C., et al. (2007). Differential expression of the flice-inhibitory protein, C-flip, in 'CD34 POT.+'cells in chronic myelogenous leukemia, polycythemia vera and essential trombocythemia. Haematologica. Pavia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Gasparotto G, Carrara RV, Zanichelli MA, Souto EX, Simões BP, Vellano C, Covas DT, Kashima S, Souza AM de, Castro FA de. Differential expression of the flice-inhibitory protein, C-flip, in 'CD34 POT.+'cells in chronic myelogenous leukemia, polycythemia vera and essential trombocythemia. Haematologica. 2007 ; 92 358.[citado 2024 nov. 16 ]
Vancouver
Gasparotto G, Carrara RV, Zanichelli MA, Souto EX, Simões BP, Vellano C, Covas DT, Kashima S, Souza AM de, Castro FA de. Differential expression of the flice-inhibitory protein, C-flip, in 'CD34 POT.+'cells in chronic myelogenous leukemia, polycythemia vera and essential trombocythemia. Haematologica. 2007 ; 92 358.[citado 2024 nov. 16 ]
Trabalho de evento-resumo periodico
Perfil de expressão do gene antiapoptótico MCL-1 em pacientes com leucemia mielóide crônica refratários ao mesilato de imatinibe (2006)
Ferreira, A. F.; Azevedo, R.; Colassanti, M.; Zanichelli, M.; Hamerschlak, N.; Amarante-Mendes, G.; Covas, Dimas Tadeu; Sashima, S.; Castro, F. A.
Source: Revista Brasileira de Hematologia e Hemoterapia. Conference titles: Congresso Brasileiro de Hematologia e Hemoterapia. Unidade: FMRP
Subjects: LEUCEMIA, CÉLULAS-TRONCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, A. F. et al. Perfil de expressão do gene antiapoptótico MCL-1 em pacientes com leucemia mielóide crônica refratários ao mesilato de imatinibe. Revista Brasileira de Hematologia e Hemoterapia. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 16 nov. 2024. , 2006
APA
Ferreira, A. F., Azevedo, R., Colassanti, M., Zanichelli, M., Hamerschlak, N., Amarante-Mendes, G., et al. (2006). Perfil de expressão do gene antiapoptótico MCL-1 em pacientes com leucemia mielóide crônica refratários ao mesilato de imatinibe. Revista Brasileira de Hematologia e Hemoterapia. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Ferreira AF, Azevedo R, Colassanti M, Zanichelli M, Hamerschlak N, Amarante-Mendes G, Covas DT, Sashima S, Castro FA. Perfil de expressão do gene antiapoptótico MCL-1 em pacientes com leucemia mielóide crônica refratários ao mesilato de imatinibe. Revista Brasileira de Hematologia e Hemoterapia. 2006 ; 28 178.[citado 2024 nov. 16 ]
Vancouver
Ferreira AF, Azevedo R, Colassanti M, Zanichelli M, Hamerschlak N, Amarante-Mendes G, Covas DT, Sashima S, Castro FA. Perfil de expressão do gene antiapoptótico MCL-1 em pacientes com leucemia mielóide crônica refratários ao mesilato de imatinibe. Revista Brasileira de Hematologia e Hemoterapia. 2006 ; 28 178.[citado 2024 nov. 16 ]
Artigo de periodico
Molecular investigation of the stromal cell-derived factor-1 chemokine in lymphoid leukemia and lymphoma patients from Brazil (2004)
Cavassin, Gabriela Gonçalves de Oliveira; De Lucca, Fernando Luiz; André, Nayara Delgado; Covas, Dimas Tadeu; Fungaro, Maria Helena Pelegrinelli; Voltarelli, Júlio César; Watanabe, Maria Angélica Ehara
Source: Blood Cells, Molecules and Diseases. Unidade: FMRP
Subjects: CITOCINAS, LINFOMA, LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAVASSIN, Gabriela Gonçalves de Oliveira et al. Molecular investigation of the stromal cell-derived factor-1 chemokine in lymphoid leukemia and lymphoma patients from Brazil. Blood Cells, Molecules and Diseases, v. 33, p. 90-93, 2004Tradução . . Disponível em: https://doi.org/10.1016/j.bcmd.2004.04.008. Acesso em: 16 nov. 2024.
APA
Cavassin, G. G. de O., De Lucca, F. L., André, N. D., Covas, D. T., Fungaro, M. H. P., Voltarelli, J. C., & Watanabe, M. A. E. (2004). Molecular investigation of the stromal cell-derived factor-1 chemokine in lymphoid leukemia and lymphoma patients from Brazil. Blood Cells, Molecules and Diseases, 33, 90-93. doi:10.1016/j.bcmd.2004.04.008
NLM
Cavassin GG de O, De Lucca FL, André ND, Covas DT, Fungaro MHP, Voltarelli JC, Watanabe MAE. Molecular investigation of the stromal cell-derived factor-1 chemokine in lymphoid leukemia and lymphoma patients from Brazil [Internet]. Blood Cells, Molecules and Diseases. 2004 ; 33 90-93.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.bcmd.2004.04.008
Vancouver
Cavassin GG de O, De Lucca FL, André ND, Covas DT, Fungaro MHP, Voltarelli JC, Watanabe MAE. Molecular investigation of the stromal cell-derived factor-1 chemokine in lymphoid leukemia and lymphoma patients from Brazil [Internet]. Blood Cells, Molecules and Diseases. 2004 ; 33 90-93.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.bcmd.2004.04.008
Artigo de periodico
Analysis of mRNA transcripts in chronic myeloid leukemica patients (1999)
Meisnner, Rosely de V.; Covas, Dimas Tadeu; Dias, Paula M. B.; Job, Fani; Leite, Márcia; Nardi, Nance B.
Source: Genetics and Molecular Biology. Unidade: FMRP
Subjects: LEUCEMIA, GENÉTICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEISNNER, Rosely de V. et al. Analysis of mRNA transcripts in chronic myeloid leukemica patients. Genetics and Molecular Biology, v. 22, n. 4, p. 475-479, 1999Tradução . . Disponível em: https://doi.org/10.1590/s1415-47571999000400003. Acesso em: 16 nov. 2024.
APA
Meisnner, R. de V., Covas, D. T., Dias, P. M. B., Job, F., Leite, M., & Nardi, N. B. (1999). Analysis of mRNA transcripts in chronic myeloid leukemica patients. Genetics and Molecular Biology, 22( 4), 475-479. doi:10.1590/s1415-47571999000400003
NLM
Meisnner R de V, Covas DT, Dias PMB, Job F, Leite M, Nardi NB. Analysis of mRNA transcripts in chronic myeloid leukemica patients [Internet]. Genetics and Molecular Biology. 1999 ; 22( 4): 475-479.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1590/s1415-47571999000400003
Vancouver
Meisnner R de V, Covas DT, Dias PMB, Job F, Leite M, Nardi NB. Analysis of mRNA transcripts in chronic myeloid leukemica patients [Internet]. Genetics and Molecular Biology. 1999 ; 22( 4): 475-479.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1590/s1415-47571999000400003

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation